NASDAQ : CELC
Celcuity Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 69.3 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.39B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 3.32B |
| Enterprise Value | 3.32B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 48.93M |
| Shares Outstanding | 48.93M |
| Shares Change (YoY) | +21.53% |
| Shares Change (QoQ) | +0.65% |
| Owned by Insiders (%) | 9.19% |
| Owned by Institutions (%) | 83.96% |
| Float | 29.72M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 28.95 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 8.93 |
| Quick Ratio | 8.68 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.37 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -1,433.70% |
| Return on Assets (ROA) | -25.78% |
| Return on Invested Capital (ROIC) | -29.46% |
| Return on Capital Employed (ROCE) | -28.15% |
| Weighted Average Cost of Capital (WACC) | 4.39% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.46M |
| Employee Count | 155 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -6.58% |
| 50-Day Moving Average | 77.67 |
| 200-Day Moving Average | 100.63 |
| Relative Strength Index (RSI) | 49.29 |
| Average Volume (20 Days) | 1,853,224 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 10.25M |
| Short Previous Month | 10.98M |
| Short % of Shares Out | 20.95% |
| Short % of Float | 34.50% |
| Short Ratio (days to cover) | 7.39 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -208.68M |
| Pretax Income | -226.48M |
| Net Income | -226.48M |
| EBITDA | -208.48M |
| EBIT | -208.68M |
| Earnings Per Share (EPS) | -$4.32 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 754.04M |
| Total Debt | 754.39M |
| Net Cash | -341,000 |
| Net Cash Per Share | -$0.01 |
| Equity (Book Value) | -12.78M |
| Book Value Per Share | -0.26 |
| Working Capital | 688.97M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -191.71M |
| Capital Expenditures | -450,000 |
| Depreciation & Amortization | 196,000 |
| Net Borrowing | 651.65M |
| Free Cash Flow | -192.16M |
| FCF Per Share | -$3.93 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -21.53% |
| Shareholder Yield | -21.53% |
| Earnings Yield | -6.37% |
| FCF Yield | -5.68% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $152.72 |
| Price Target Difference | 125.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |